Drug Products, Labeling, and Packaging
Policy Positions
0801 - Alternative Drug Coding System [HTML]
0808 - Disclosure of Excipients in Drug Products [HTML]
0715 - Patient Access to Orphan Drug Products [HTML]
0720 - Standardizing Prefixes and Suffixes in Drug Product Names [HTML]
0618 - Elimination of Surface Contamination on Vials of Hazardous Drugs [HTML]
0501 - Mandatory Labeling of the Presence of Latex [HTML]
0402 - Ready-to-Use Packaging for All Settings [HTML]
0404 - Standardization, Automation, and Expansion of Manufacturer-Sponsored Patient-Assistance Programs [HTML]
0309 – Unit Dose Packaging Availability [HTML]
0002 - Drug Shortages [HTML]
9707 - Pediatric Dosage [HTML]
9608 - Use of Color to Identify Drug Products [HTML]
9309 - Expiration Dating of Pharmaceutical Products [HTML]
9211 - Tamper-Evident Packaging on Topical Products [HTML]
9011 - Drug Nomenclature [HTML]
8709 - Codes on Solid Dosage Forms of Prescription Drug Products [HTML]
8612 - International System of Units [HTML]
8613 - Elimination of Apothecary System [HTML]
8310 - Size, Color, and Shape of Drug Products [HTML]
All the ASHP policies listed above [PDF]
Marketing
Policy Positions
0714 - Restricted Drug Distribution [HTML]
0603 - Medication Management for Patient Assistance Programs [HTML]
0605 - Pharmaceutical Distribution Systems [HTML]
0609 - Direct-to-Consumer Advertising of Prescription and Nonprescription Medications [HTML]
9702 - Drug Samples [HTML]
9703 - Manufacturer-Sponsored Patient-Assistance Programs [HTML]
All the ASHP policies listed above [PDF]
Guidelines
Activities of Vendors’ Representatives in Organized Health Care Systems [PDF]